Table 2.
Diabetic complications of the subjects in the structured health care program and controls
|
Parameter |
SHC |
Controls |
|---|---|---|
| n (%) | (n%) | |
| VPT < 4/8 |
654 (95.6) |
457 (90.0) |
| CAN |
289 (42.3) |
n. d. |
| retinopathy |
|
|
| background |
561 (82.0) |
n. d. |
| proliferative |
55 (8.0) |
n. d. |
| Microalbuminuria |
269 (39.2) |
n. d. |
| creatinine >130μmol/l |
104 (15.2) |
71 (14.1) |
| prior amputation |
249 (36.4) |
|
| toe |
152 (22.2) |
n. d. |
| transmetatarsal |
34 (5.0) |
n. d. |
| below the knee |
40 (5.8) |
73 (14.4) |
| above the knee |
23 (3.4) |
53 (10.5) |
| CAD |
567 (82.9) |
396 (78.1) |
| prior AMI |
47 (6.9) |
41 (8.0) |
| prior stroke |
51 (7.5) |
48 (9.5) |
| hypertension |
621 (90.8) |
441 (87.0) |
| dyslipidemia |
540 (78.9) |
n. d. |
| smoking | 231 (33.8) | 158 (31.2) |
VPT vibration perception threshold.
CAN cardiac anatomic neuropathy.
CAD coronary artery disease.
SHC structured health care group.